Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?
Saved in:
| Title: | Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy? |
|---|---|
| Authors: | Durcan R; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge CB2 0SZ, UK., O'Callaghan C; Brain and Mind Centre and School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2050, Australia., Rowe JB; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK. |
| Source: | Brain communications [Brain Commun] 2025 Aug 25; Vol. 7 (5), pp. fcaf310. Date of Electronic Publication: 2025 Aug 25 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755125 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-1297 (Electronic) Linking ISSN: 26321297 NLM ISO Abbreviation: Brain Commun Subsets: In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2632-1297 |
|---|---|
| DOI: | 10.1093/braincomms/fcaf310 |
